A  ||| S:0 E:2 ||| DT
role  ||| S:2 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
negative  ||| S:10 E:19 ||| JJ
pressure  ||| S:19 E:28 ||| NN
therapy  ||| S:28 E:36 ||| NN
in  ||| S:36 E:39 ||| IN
the  ||| S:39 E:43 ||| DT
treatment  ||| S:43 E:53 ||| NN
of  ||| S:53 E:56 ||| IN
surgical  ||| S:56 E:65 ||| JJ
wound  ||| S:65 E:71 ||| NN
infection  ||| S:71 E:81 ||| NN
after  ||| S:81 E:87 ||| IN
intramedullary  ||| S:87 E:102 ||| FW
osteosynthesis  ||| S:102 E:117 ||| FW
in  ||| S:117 E:120 ||| FW
pertrochanteric  ||| S:120 E:136 ||| FW
femoral  ||| S:136 E:144 ||| FW
fracture  ||| S:144 E:153 ||| FW
Fractures  ||| S:153 E:163 ||| NNP
of  ||| S:163 E:166 ||| IN
the  ||| S:166 E:170 ||| DT
proximal  ||| S:170 E:179 ||| JJ
femur  ||| S:179 E:185 ||| NNS
are  ||| S:185 E:189 ||| VBP
specific  ||| S:189 E:198 ||| JJ
to  ||| S:198 E:201 ||| TO
older  ||| S:201 E:207 ||| JJR
adults ||| S:207 E:213 ||| NNS
.  ||| S:213 E:215 ||| .
Today ||| S:215 E:220 ||| NN
,  ||| S:220 E:222 ||| ,
life  ||| S:222 E:227 ||| NN
expectancy  ||| S:227 E:238 ||| NN
for  ||| S:238 E:242 ||| IN
men  ||| S:242 E:246 ||| NNS
and  ||| S:246 E:250 ||| CC
women  ||| S:250 E:256 ||| NNS
is  ||| S:256 E:259 ||| VBZ
increasing ||| S:259 E:269 ||| VBG
,  ||| S:269 E:271 ||| ,
so  ||| S:271 E:274 ||| RB
one  ||| S:274 E:278 ||| CD
can  ||| S:278 E:282 ||| MD
expect  ||| S:282 E:289 ||| VB
an  ||| S:289 E:292 ||| DT
increased  ||| S:292 E:302 ||| JJ
number  ||| S:302 E:309 ||| NN
of  ||| S:309 E:312 ||| IN
hip  ||| S:312 E:316 ||| JJ
fractures ||| S:316 E:325 ||| NN
.  ||| S:325 E:327 ||| .
Elderly  ||| S:327 E:335 ||| JJ
people  ||| S:335 E:342 ||| NNS
suffer  ||| S:342 E:349 ||| VBP
from  ||| S:349 E:354 ||| IN
associated  ||| S:354 E:365 ||| JJ
diseases  ||| S:365 E:374 ||| NNS
that  ||| S:374 E:379 ||| WDT
may  ||| S:379 E:383 ||| MD
compromise  ||| S:383 E:394 ||| VB
the  ||| S:394 E:398 ||| DT
biological  ||| S:398 E:409 ||| JJ
potential  ||| S:409 E:419 ||| NN
in  ||| S:419 E:422 ||| IN
healing  ||| S:422 E:430 ||| NN
of  ||| S:430 E:433 ||| IN
surgical  ||| S:433 E:442 ||| JJ
wounds ||| S:442 E:448 ||| NNS
.  ||| S:448 E:450 ||| .
On  ||| S:450 E:453 ||| IN
the  ||| S:453 E:457 ||| DT
other  ||| S:457 E:463 ||| JJ
hand ||| S:463 E:467 ||| NN
,  ||| S:467 E:469 ||| ,
there  ||| S:469 E:475 ||| EX
is  ||| S:475 E:478 ||| VBZ
an  ||| S:478 E:481 ||| DT
increased  ||| S:481 E:491 ||| JJ
number  ||| S:491 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
microorganisms  ||| S:501 E:516 ||| JJ
resistant  ||| S:516 E:526 ||| NN
to  ||| S:526 E:529 ||| TO
antimicrobial  ||| S:529 E:543 ||| VB
drugs ||| S:543 E:548 ||| NNS
,  ||| S:548 E:550 ||| ,
so  ||| S:550 E:553 ||| RB
an  ||| S:553 E:556 ||| DT
increased  ||| S:556 E:566 ||| JJ
number  ||| S:566 E:573 ||| NN
of  ||| S:573 E:576 ||| IN
postoperative  ||| S:576 E:590 ||| JJ
infections  ||| S:590 E:601 ||| NNS
can  ||| S:601 E:605 ||| MD
be  ||| S:605 E:608 ||| VB
expected ||| S:608 E:616 ||| VBN
.  ||| S:616 E:618 ||| .
With  ||| S:618 E:623 ||| IN
conventional  ||| S:623 E:636 ||| JJ
treatment  ||| S:636 E:646 ||| NN
methods  ||| S:646 E:654 ||| NNS
of  ||| S:654 E:657 ||| IN
postoperative  ||| S:657 E:671 ||| JJ
infections  ||| S:671 E:682 ||| NNS
where  ||| S:682 E:688 ||| WRB
the  ||| S:688 E:692 ||| DT
osteo-synthetic  ||| S:692 E:708 ||| JJ
material  ||| S:708 E:717 ||| NN
is  ||| S:717 E:720 ||| VBZ
present  ||| S:720 E:728 ||| JJ
in  ||| S:728 E:731 ||| IN
tissue ||| S:731 E:737 ||| NN
,  ||| S:737 E:739 ||| ,
negative  ||| S:739 E:748 ||| JJ
pressure  ||| S:748 E:757 ||| NN
therapy  ||| S:757 E:765 ||| NN
is  ||| S:765 E:768 ||| VBZ
gradually  ||| S:768 E:778 ||| RB
taking  ||| S:778 E:785 ||| VBG
an  ||| S:785 E:788 ||| DT
increasingly  ||| S:788 E:801 ||| RB
important  ||| S:801 E:811 ||| JJ
role  ||| S:811 E:816 ||| NN
in  ||| S:816 E:819 ||| IN
the  ||| S:819 E:823 ||| DT
treatment  ||| S:823 E:833 ||| NN
of  ||| S:833 E:836 ||| IN
these  ||| S:836 E:842 ||| DT
conditions ||| S:842 E:852 ||| NNS
.  ||| S:852 E:854 ||| .
Because  ||| S:854 E:862 ||| IN
of  ||| S:862 E:865 ||| IN
its  ||| S:865 E:869 ||| PRP$
simple  ||| S:869 E:876 ||| JJ
application  ||| S:876 E:888 ||| NN
in  ||| S:888 E:891 ||| IN
hospital  ||| S:891 E:900 ||| NN
or  ||| S:900 E:903 ||| CC
outpatient  ||| S:903 E:914 ||| JJ
setting  ||| S:914 E:922 ||| NN
and  ||| S:922 E:926 ||| CC
good  ||| S:926 E:931 ||| JJ
comfort  ||| S:931 E:939 ||| NN
with  ||| S:939 E:944 ||| IN
no  ||| S:944 E:947 ||| DT
pain  ||| S:947 E:952 ||| NN
for  ||| S:952 E:956 ||| IN
the  ||| S:956 E:960 ||| DT
patient ||| S:960 E:967 ||| NN
,  ||| S:967 E:969 ||| ,
negative  ||| S:969 E:978 ||| JJ
pressure  ||| S:978 E:987 ||| NN
therapy  ||| S:987 E:995 ||| NN
contributes  ||| S:995 E:1007 ||| VBZ
significantly  ||| S:1007 E:1021 ||| RB
to  ||| S:1021 E:1024 ||| TO
healing  ||| S:1024 E:1032 ||| VB
of  ||| S:1032 E:1035 ||| IN
the  ||| S:1035 E:1039 ||| DT
wounds  ||| S:1039 E:1046 ||| NNS
without  ||| S:1046 E:1054 ||| IN
removing  ||| S:1054 E:1063 ||| VBG
osteosynthetic  ||| S:1063 E:1078 ||| JJ
material  ||| S:1078 E:1087 ||| NN
from  ||| S:1087 E:1092 ||| IN
the  ||| S:1092 E:1096 ||| DT
wound ||| S:1096 E:1101 ||| NN
.  ||| S:1101 E:1103 ||| .
